England - London • TMT (technology, media and telecoms)
Simmons & Simmons
We only have limited information for this firm. Consider the following firms which have provided more information:
A team that possesses ‘very strong technical IP and industry knowledge’, Simmons & Simmons leverages its technical strength to maintain a strong practice in the healthcare and life sciences sectors, alongside communications engineering technology including mobile phones and infrastructure. Michael Gavey leads the team, with experience in advising some of the largest biopharma clients on numerous transactions and disputes. Michael Burdon and Scott Parker are well-versed in the realm of patent litigation, with the latter primarily acting for pharma and biotech companies. Angus McLean stands out in the fintech arena, while Andrew Hutchinson’s life sciences expertise further strengthens the practice. ’Exceptional’ Priya Nagpal routinely handles multijurisdictional disputes that involve disruptive technologies such as medical devices, software and big data, alongside particular expertise in digital health matters.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
'Simmons have unrivalled expertise when it comes to digital health issues, especially on IP, data protection and regulatory matters.’
‘Priya Nagpal is a key contact at Simmons. Priya is an exceptional IP litigator and brings a wealth of experience and knowledge, enabling her to find elegant solutions to complex IP problems.'
Abbreviated data is displayed for this firm.
Key clients
- Boston Scientific Corp
- Xiamoi
Abbreviated data is displayed for this firm.
Work highlights
- Advised Boston Scientific in a dispute with Cook Medical are engaged in a patent battle spanning the US, USPTO, Germany, EPO and the Netherlands. Boston Scientific is claiming that its patents (for endoscopic clips which prevent internal bleeding) have been infringed by Cook Medical’s Instinct Clip in multiple countries.
- Advised GSK, Amgen, AstraZeneca, Merck Sharp & Dohme, Johnson & Johnson, Alnylam, Roche and Regeneron on a long term multi-million collaboration agreement with Our Future Health.
Abbreviated data is displayed for this firm.